MSRA Brain Bank will receive a $500,000 grant from the NSW Government, which will allow researchers to utilise advanced technologies and directly target new
A review of Gilenya by the EMA has been initiated following the report of a patient in the USA who died 24 hours after taking Gilenya. The review also includes
